术后新鼻窦腔形成后皮质类固醇冲洗治疗弥漫型2型或嗜酸性慢性鼻窦炎的评估
这项前瞻性队列研究纳入222例原发弥漫型2型或嗜酸性慢性鼻窦炎成人患者,均接受新鼻窦腔ESS及术后皮质类固醇冲洗。中位随访2.2年,87.8%患者疾病控制良好,67.0%患者SNOT-22维持临床意义改善,提示按炎症性疾病管理可获长期控制。
要点
- 新鼻窦腔ESS联合术后皮质类固醇冲洗可使多数弥漫型2型CRS患者长期控制良好。
- 87.8%患者达到良好控制,息肉复发、长期口服激素、生物制剂及修正手术比例均较低。
- 67.0%患者SNOT-22及鼻部子域评分维持临床意义改善。
核心结论
- 原发弥漫型2型或嗜酸性CRS按炎症性疾病进行多模式管理,可能实现长期疾病控制和症状负担减轻。
- 术后皮质类固醇冲洗在该人群中似乎可根据疾病活动性成功自我递减。
研究设计与样本
- 共222例原发弥漫型2型或嗜酸性CRS患者,男性126例(56.8%),平均年龄54.8(13.6)岁,中位随访2.2(2.2)年。
- 2型炎症定义为鼻窦黏膜活检每高倍视野嗜酸性粒细胞超过10个。
主要发现
- 195例(87.8%)疾病控制良好,16例(7.2%)息肉复发,7例(3.2%)长期口服激素,5例(2.3%)使用生物制剂,8例(3.6%)接受修正性息肉切除术。
- 134例(67.0%)在末次随访时SNOT-22及鼻部子域评分维持临床意义改善。
- 疾病控制不佳与冲洗依从性差无关。
关键数值与推荐
- 不良控制定义为息肉复发(单侧超过1个鼻窦区域息肉生长)、长期全身治疗(生物制剂或连续口服激素≥3个月)或涉及息肉切除的修正手术。
- 无上述标准为控制良好,符合1项及以上为控制不佳。
- 术后每日鼻腔冲洗240 mL,含倍他米松1 mg或布地奈德1 mg,持续3至6个月,后按需递减至最低每周2-3次。
临床怎么用
- 对原发弥漫型2型或嗜酸性CRS,可采用新鼻窦腔ESS联合术后皮质类固醇冲洗的多模式方案。
- 术后冲洗可按疾病活动性自我递减,不必因担心依从性差而过度干预。
局限性
- 原文未报告
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Eosinophilic chronic rhinosinusitis (eCRS), contemporarily classified as diffuse type 2 dominant chronic rhinosinusitis (CRS), is characterized by eosinophil-dominant mucosal inflammation. Contemporary management of eCRS as an inflammatory airway condition is multimodal with corticosteroid irrigations after the surgical creation of a neosinus cavity. OBJECTIVES: To assess long-term treatment outcomes in patients with primary diffuse type 2 CRS or eCRS receiving multimodal treatment. DESIGN, SETTING, AND PARTICIPANTS: A prospective cohort study of patients seen in a tertiary rhinology practice recruited from May 2010 to November 2018 was conducted. Follow-up duration was 12 months or more following endoscopic sinus surgery (ESS) with a neosinus cavity formed. Data analysis was performed from August to November 2020. Consecutive adult (≥18 years) patients diagnosed with primary diffuse type 2 dominant CRS or eCRS based on the European Position Paper on Rhinosinusitis and Nasal Polyps 2020 criteria were included. Type 2 inflammation was defined as more than 10 eosinophils per high-power field obtained from sinus mucosal biopsy and managed with neosinus cavity ESS and ongoing corticosteroid irrigations. Exclusion criteria were less than 12 months of follow-up and secondary CRS. INTERVENTIONS: Endoscopic sinus surgery with complete removal of intersinus bony partitions to create a neosinus cavity. Nasal irrigation (240 mL) with betamethasone, 1 mg, or budesonide, 1 mg, daily for 3 to 6 months after ESS and tapered to an as-needed basis (minimum, 2-3 per week). MAIN OUTCOMES AND MEASURES: Poor control was defined as polyp recurrence (polyp growth in >1 sinus area on a single side), use of long-term systemic therapy (biologic therapy or ≥3 consecutive months of oral corticosteroids), and revision surgery involving polypectomy. The disease in patients with no poor control criteria was defined as well controlled, and the disease in those with 1 or more criteria was considered poorly controlled. Maintenance medical therapy use and patient-reported outcomes based on the 22-item Sinonasal Outcomes Test for preoperative and last follow-up were collected. RESULTS: Of the 222 participants recruited with primary diffuse type 2 dominant CRS or eCRS and minimum of year of follow-up, 126 were men (56.8%). Mean (SD) age was 54.8 (13.6) years, and median (SD) follow-up was 2.2 (2.2) years. Of the 222 patients, 195 (87.8%) had well-controlled disease, 16 (7.2%) had polyp recurrence, 7 (3.2%) continued to receive long-term oral corticosteroid therapy, 5 (2.3%) received biologic therapy, and 8 (3.6%) underwent a revision polypectomy. Clinically meaningful change on the 22-item Sinonasal Outcomes Test and the nasal subdomain score was maintained at the last follow-up in 134 patients (67.0%). Poor disease control was not associated with poor adherence to irrigation use. CONCLUSIONS AND RELEVANCE: The findings of this cohort study suggest that long-term disease control and reduction in symptom burden in patients with primary diffuse type 2 CRS or eCRS might be achieved when managed as an inflammatory disorder. Maintenance corticosteroid irrigations in the population examined appeared to be successfully self-tapered to disease activity.
引用
- Li W, Ho J, Grayson JW, et al. Evaluation of Diffuse Type 2 Dominant or Eosinophilic Chronic Rhinosinusitis With Corticosteroid Irrigation After Surgical Neosinus Cavity Formation. JAMA Otolaryngol Head Neck Surg. 2021. PMID: 33538760. doi:10.1001/jamaoto.2020.5286
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。